INFU · InfuSystem Holdings, Inc
$12.27
-0.21 (-1.68%)
At close · Aug 14
Market Cap
$244.38M
Shares
19.92M
InfuSystem Holdings, Inc Earnings Call Transcripts
Every quarterly earnings call for InfuSystem Holdings, Inc (INFU) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲2.7%
$27.28M
$443,000
'22 Q3
22-11-08
▲8.7%
$28.83M
$107,000
'22 Q4
23-03-15
▲13.5%
$30.37M
−$324,000
'23 Q1
23-05-04
▲17.4%
$31.73M
$435,000
'23 Q2
23-08-03
▲17%
$31.91M
$689,000
'23 Q3
23-11-07
▲10.2%
$31.77M
$72,000
'23 Q4
24-03-14
▲5.4%
$32.00M
−$1.11M
'24 Q1
24-05-09
▲6.2%
$33.70M
$717,000
'24 Q2
24-08-08
▲10.7%
$35.32M
$1.81M
'24 Q3
24-11-07
▲6.5%
$33.85M
$933,000
'24 Q4
25-03-04
▲8.5%
$34.72M
−$267,000
'25 Q1
25-05-08
▲6.8%
$36.00M
$2.60M
'25 Q2
25-08-05
▲3.3%
$36.49M
$2.26M
'25 Q3
25-11-04
▲7%
$36.23M
$2.04M
'25 Q4
26-02-24
▼3%
$33.68M
$1.02M
'26 Q1
26-05-07
LATEST
▲2.6%
$36.93M
$3.23M
'26 Q2
26-08-04
Earnings call
FY26 · Q2
2026-08-04
InfuSystem Holdings, Inc. Second Quarter 2026 Financial Results Conference Call
Positive tone
Lymphedema business and CMS prior authorization
ERP system implementation benefits
Growth timeline and future aspirations
Revenue
$36.93M
▲ 2.6% YoY Diluted EPS
$0.15
▲ 25% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
InfuSystem Holdings, Inc Q1 FY2026 Earnings Call
Positive tone
Wound care growth
ERP system implementation
GE Healthcare contract restructuring
Revenue
$33.68M
▼ 3% YoY Diluted EPS
$0.05
Gross margin
58.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
InfuSystem Holdings, Inc Q4 FY2025 Earnings Call
Confident tone
Q4 financial highlights
2026 financial outlook
Profitability and gross margin
Revenue
$36.23M*
▲ 7% YoY Gross margin
56.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
InfuSystem Holdings, Inc Q3 FY2025 Earnings Call
Positive tone
Financial results and margin expansion
Wound Care growth and integration
Oncology business performance
Revenue
$36.49M
▲ 3.3% YoY Diluted EPS
$0.11
▲ 37.5% YoY Gross margin
57.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
InfuSystem Holdings, Inc Q2 FY2025 Earnings Call
Positive tone
Margin expansion and profitability
Oncology business
ChemoMouthpiece reimbursement
Revenue
$36.00M
▲ 6.8% YoY Diluted EPS
$0.12
▲ 300% YoY Gross margin
55.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
InfuSystem Holdings, Inc Q1 FY2025 Earnings Call
Confident tone
Q1 revenue and EBITDA growth
CEO succession and leadership transition
Segment performance (Patient Services and Device Solutions)
Revenue
$34.72M
▲ 8.5% YoY Diluted EPS
$-0.01
Gross margin
55.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
InfuSystem Holdings, Inc Q4 FY2024 Earnings Call
Confident tone
Revenue Growth Across Business Lines
Wound Care Initiative Ramp-Up
2024 Accretion Year Results
Revenue
$33.85M*
▲ 6.5% YoY Gross margin
53.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
InfuSystem Holdings, Inc Q3 FY2024 Earnings Call
Confident tone
Sanara / Chemo Mouthpiece joint venture
Device Solutions segment
Revenue growth and records
Revenue
$35.32M
▲ 10.7% YoY Diluted EPS
$0.08
▲ 166.7% YoY Gross margin
53.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
InfuSystem Holdings, Inc Q2 FY2024 Earnings Call
Confident tone
Negative Pressure Wound Therapy expansion
NOPAIN Act and Pain Management
Oncology segment performance
Revenue
$33.70M
▲ 6.2% YoY Diluted EPS
$0.03
▲ 50% YoY Gross margin
49.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
InfuSystem Holdings, Inc Q1 FY2024 Earnings Call
Confident tone
Strategic outlook and pipeline
Biomedical/Wound Care programs
Profitability and margin expansion
Revenue
$32.00M
▲ 5.4% YoY Diluted EPS
$-0.05
Gross margin
51.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-14
InfuSystem Holdings, Inc Q4 FY2023 Earnings Call
Confident tone
GE Healthcare biomedical services contract
Wound Care and Sanara joint venture
Core oncology and pump rental business
Revenue
$31.77M*
▲ 10.2% YoY Gross margin
52.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
InfuSystem Holdings, Inc Q3 FY2023 Earnings Call
Revenue
$31.91M
▲ 17% YoY Diluted EPS
$0.03
▲ 50% YoY Gross margin
48.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
InfuSystem Holdings, Inc Q2 FY2023 Earnings Call
Revenue
$31.73M
▲ 17.4% YoY Diluted EPS
$0.02
Gross margin
49.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
InfuSystem Holdings, Inc Q1 FY2023 Earnings Call
Revenue
$30.37M
▲ 13.5% YoY Diluted EPS
$-0.02
Gross margin
49.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-15
InfuSystem Holdings, Inc Q4 FY2022 Earnings Call
Revenue
$28.83M*
▲ 8.7% YoY Gross margin
48.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
InfuSystem Holdings, Inc Q3 FY2022 Earnings Call
Revenue
$27.28M
▲ 2.7% YoY Diluted EPS
$0.02
Gross margin
59.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
InfuSystem Holdings, Inc Q2 FY2022 Earnings Call
Revenue
$27.04M
▲ 8.9% YoY Diluted EPS
$-0.01
▼ 125% YoY Gross margin
55.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
InfuSystem Holdings, Inc Q1 FY2022 Earnings Call
Revenue
$26.76M
▲ 9.4% YoY Diluted EPS
$-0.02
▼ 166.7% YoY Gross margin
57.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
InfuSystem Holdings, Inc Q4 FY2021 Earnings Call
Revenue
$26.52M*
▲ 7.3% YoY Gross margin
51.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-15
InfuSystem Holdings, Inc Q3 FY2021 Earnings Call
Revenue
$26.57M
▲ 5.7% YoY Diluted EPS
$-0.02
▼ 114.3% YoY Gross margin
57.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
InfuSystem Holdings, Inc Q2 FY2021 Earnings Call
Revenue
$24.83M
▼ 4.5% YoY Diluted EPS
$0.04
▼ 78.9% YoY Gross margin
60.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
InfuSystem Holdings, Inc Q1 FY2021 Earnings Call
Revenue
$24.46M
▲ 13.5% YoY Diluted EPS
$0.03
Gross margin
59.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-17
InfuSystem Holdings, Inc Q4 FY2020 Earnings Call
Revenue
$24.71M*
▲ 13.8% YoY Gross margin
60.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-12
InfuSystem Holdings, Inc Q3 FY2020 Earnings Call
Revenue
$25.12M
▲ 16.9% YoY Diluted EPS
$0.14
▲ 180% YoY Gross margin
60.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
InfuSystem Holdings, Inc Q2 FY2020 Earnings Call
Revenue
$26.00M
▲ 31.8% YoY Diluted EPS
$0.19
▲ 850% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
InfuSystem Holdings, Inc Q1 FY2020 Earnings Call
Revenue
$21.55M
▲ 18.5% YoY Diluted EPS
$-0.02
Gross margin
58.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-19
InfuSystem Holdings, Inc Q4 FY2019 Earnings Call
Revenue
$21.71M*
▲ 23.6% YoY Gross margin
59.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
1337013
CUSIP
45685K102
13F (30d)
99 filings
96 filers
Visit website
Investor relations